Switching from branded to generic glatiramer acetate: two-year MRI data from the GATE trial demonstrates continuous efficacy

被引：0
|
作者：
Barkhof, F. [1 ]
Belova, A. [2 ]
Selmaj, K. [3 ]
Wolf, C. [4 ]
van den Tweel, E. R. W. [5 ]
Oberye, J. J. L. [5 ]
Mulder, R. [5 ]
Koper, N. P. [5 ]
Cohen, J. A. [6 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Radiol, Amsterdam, Netherlands
[2] Res Inst Traumatol & Orthopaedy, Funct Diagnost, Nizhnii Novgorod, Russia
[3] Med Univ Lodz, Lodz, Poland
[4] Lycalis Sprl, Brussels, Belgium
[5] Synthon BV, Nijmegen, Netherlands
[6] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P522
引用
收藏
页码：231 / 232
页数：2
相关论文
共 50 条
  • [1] Switching from branded to generic glatiramer acetate: two-year clinical data from the GATE trial further support the continued efficacy and tolerability of generic glatiramer acetate
    Cohen, J. A.
    Belova, A.
    Barkhof, F.
    Wolf, C.
    van den Tweel, E. R. W.
    Oberye, J. J. L.
    Mulder, R.
    Koper, N. P.
    Selmaj, K.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 536 - 537
  • [2] Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results
    Selmaj, Krzysztof
    Barkhof, Frederik
    Belova, Anna N.
    Wolf, Christian
    van den Tweel, Evelyn R. W.
    Oberye, Janine J. L.
    Mulder, Roel
    Egging, David F.
    Koper, Norbert P.
    Cohen, Jeffrey A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (14) : 1909 - 1917
  • [3] Tolerability and Acceptance of Switching from Brand to Generic Glatiramer Acetate in Multiple Sclerosis
    Maraffi, Isabella
    Mallucci, Giulia
    Disanto, Giulio
    Sacco, Rosaria
    Tiberti, Massimiliano
    Gobbi, Claudio
    Zecca, Chiara
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [4] Generic glatiramer acetate is equivalent to copaxone on efficacy and safety: results of the randomized double-blind GATE trial in multiple sclerosis
    Cohen, J. A.
    Belova, A.
    Selmaj, K.
    Wolf, C.
    Oberye, J. J. L.
    van den Tweel, E. R. W.
    Koper, N. P.
    Voortman, G.
    Barkhof, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 38 - 39
  • [5] COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg daily
    Ziemssen, T.
    Bajenaru, O.
    Carra, A.
    de Klippel, N.
    de Sa, J.
    Edland, A.
    Frederiksen, J.
    Heinzlef, O.
    Karageorgiou, K.
    Landtblom, A. M.
    Macias Islas, M.
    Tubridy, N.
    Gilgun-Sherki, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 444 - 445
  • [6] Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
    Gianotti, Nicola
    Poli, Andrea
    Galli, Laura
    Franzin, Michela
    Tadini, Patrizia
    Galizzi, Nadia
    Carbone, Alessia
    Merli, Marco
    Muccini, Camilla
    Oltolini, Chiara
    Andolina, Andrea
    Spagnuolo, Vincenzo
    Lazzarin, Adriano
    Castagna, Antonella
    PLOS ONE, 2017, 12 (08):
  • [7] Two-year data from the cornea registry in Oslo
    Haughom, B.
    Drolsum, L.
    ACTA OPHTHALMOLOGICA, 2010, 88 : 38 - 38
  • [8] SAFETY AND EFFICACY CONCERNS IN SWITCHING PATIENTS WITH OVERACTIVE BLADDER (OAB) SYMPTOMS FROM BRANDED TO GENERIC ANTICHOLINERGIC MEDICATIONS
    Kaplan, Steven A.
    Chung, Doreen E.
    Sandhu, Jaspreet S.
    Te, Alexis E.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 675 - 675
  • [9] Slowing of disability progression in patients receiving continuous glatiramer acetate compared with those withdrawing from therapy: 10-year results from an ongoing trial
    Johnson, K
    Ford, C
    Panitch, H
    Lisak, R
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S257 - S257
  • [10] Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy
    Bonifacio, Massimiliano
    Scaffidi, Luigi
    Binotto, Gianni
    Miggiano, Maria Cristina
    Danini, Marco
    Minotto, Claudia
    Griguolo, Davide
    Marin, Luciana
    Frison, Luca
    D'Amore, Fabio
    Basso, Marco
    Sartori, Roberto
    Tinelli, Martina
    Stulle, Manuela
    Fortuna, Stefania
    Bonalumi, Angela
    Bertoldero, Giovanni
    De Biasi, Ercole
    Ruggeri, Marco
    Semenzato, Gianpietro
    Fanin, Renato
    Pizzolo, Giovanni
    Krampera, Mauro
    Tiribelli, Mario
    LEUKEMIA RESEARCH, 2018, 74 : 75 - 79
12345